Anthony Doyle, CFO of Biocryst Pharmaceuticals BCRX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 24/12/19.

AD

AD

Anthony Doyle

CFO

Company

Biocryst Pharmaceuticals BCRX

First filing

23/12/18

Trades

9 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

24/12/19

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Biocryst PharmaceuticalsBCRX	Open-market buy	24/05/14	24/05/15	36,300 sh	$5.57	$202,191	+15.8%